Class Limited Shares Decline Following The Surprise Exit Of CEO Mr. Kevin Bungard

class ltd

On 24 October 2018, Class Limited (ASX: CL1) announced that Mr. Kevin Bungard is stepping down from his role of CEO by mutual agreement with the board. Following this news, the share price of the company declined by 6.944 percent as on 25 October 2018.

Mr. Kevin Bungard has been CEO since April 2014 and led the company through its successful listing on the ASX in December 2015. The company’s board and Mr. Bungard have mutually agreed that a new leadership is required for the next stage of the company’s growth. The Board has started the search for the new CEO and it will start evaluating the potential internal successors. It has been decided that the current CFO Mr. Glenn Day will take on the role as an acting CEO until the new CEO is appointed. Mr. Bungard will remain available to the company for consultation during the balance of his 3 months’ notice period. [optin-monster-shortcode id=”swikrbu1d9j9aq0o4cko”]

The company recently held its Annual General Meeting on 15 October 2018 in which the company reported strong revenue growth and profit margins in FY 2018. The operating revenue increased by 18 percent to $34 million in FY 2018 compared to the prior corresponding year. The EBITDA of the company increased by 14 percent to $15.9 million in FY 2018. The NPAT of the company increased by 9 percent to $8.7 million in FY 2018 as compared to last year. The earnings per share of the company witnessed a growth of 8 percent in FY 2018. In FY 2018, the company’s portfolio grew by 83 percent by adding 2,695 new accounts. The company believes that there is a large opportunity in the portfolio administration space and it is investing heavily in the product, including 3 developing deeper integrations with financial planning tools and enhancements for multidisciplinary practices. In FY 2018, the company significantly invested in a new team led by Mr. Glenn Poynton, to grow partner revenue beyond the 4 percent that it currently contributes. The company is working to increase revenue share from partner products and expanding the partner network. The company is also actively reviewing opportunities for alliances (including M&A) in adjacent markets. The company is having a clear strategy to deliver long-term success and remain positive about the growth of the business moving forward. The company is focused on growing its market share in both cloud-based SMSF (Self-Managed Super Fund) and non-SMSF wealth accounting software. With desktop and excel users migrating to cloud and increased switching from other cloud products the outlook for SMSF growth in FY 2019 is very positive.

In the last six months, the share price of the company increased by 0.92 percent as on 24 October 2018, traded at a PE level of 29.230x. CL1’s shares traded at $2.010 with a market capitalization of $254.15 million as on 25 October 2018 (AEST 12:38 PM).


Disclaimer

The advice given by Kalkine Pty Ltd and provided on this website is general information only and it does not take into account your investment objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. Kalkinemedia.com and associated websites are published by Kalkine Pty Ltd ABN 34 154 808 312 (Australian Financial Services License Number 425376). website), employees and/or associates of Kalkine Pty Ltd do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations.

Join Our Discussion

Start discussion with value Investors for ASX Stock Market Investment and Opinion.


6 Cannabis Stocks under Investor’s Limelight…

Cannabis companies that sell both medicinal weed and recreational pot. Marijuana stocks to look at. Marijuana mergers and acquisitions. Dispensary data analytics. Upcoming marijuana IPO’s Those phrases have become increasingly common as marijuana legalization spreads.

Global spending on legal cannabis is expected to grow 230% to $32 billion in 2020 as compared to $9.5 in 2017, according to Arcview Market Research and BDS Analytics. As of June 29, 2018 the United States Marijuana Index, despite a lot of uncertainty around regulations, has over the past 1 year gained 71.49%, as compared to about 12% gain seen by the S&P 500.

Click here for your FREE Report